This receptor modulation triggers a cascade of intracellular signaling events that ultimately result in the activation of hormone-sensitive lipase, the enzyme responsible for breaking down stored triglycerides into free fatty acids and glycerol
In practice, this means more nausea during the first weeks of each dose increase
In AD, cerebrovascular dysfunction occurs earlier among E4 carriers (Veitch et al., 2019), which could lead to impairments in nutrient sensing and metabolite exchange between the brain and periphery, thereby negatively impacting brain bioenergetics by rendering brain areas of high energetic needs (e.g., the hippocampus) vulnerable to pathologies such as amyloid (Veitch et al., 2019
Improves mood and sense of well-being Women who undergo menopause treatment experience a decreased sense of anxiety and depression
Improved blood glucose control from GLP-1 therapy typically reduces urination by eliminating osmotic diuresis caused by excess glucose in urine
[2] [4] GLP-1 receptor agonists work by mimicking the action of naturally occurring GLP-1 , a hormone released by the intestine in response to food intake